Search for the latest oncology news by tumour type
Gene signature found for poor response to standard chemotherapy in rare uterine cancer
Women who don’t survive a rare and aggressive uterine cancer called uterine serous carcinoma, have…
Search for the latest oncology news by tumour type
Women who don’t survive a rare and aggressive uterine cancer called uterine serous carcinoma, have…
Many cells in the inner lining of the uterus carry ‘cancer-driving’ mutations that frequently arise…
A risk prediction model that combined genetic and clinical factors with circulating biomarkers identified people…
Persistent inflammation of the pancreas (chronic pancreatitis) is a known risk factor for developing pancreatic…
A team of researchers at University of California San Diego School of Medicine and Moores…
In today’s edition of The Oncology Podcast, Rachael Babin talks to Associate Professor Matt Naylor…
The U.S. Food and Drug Administration (FDA) approved tucatinib in combination with chemotherapy (trastuzumab and capecitabine)…
A sizable subset of people with breast cancer, those who have small tumours and a…
In an analysis that included information on adults diagnosed with colorectal cancer between 40 and…
In today’s edition of The Oncology Podcast, Rachael Babin talks to Dr Michelle…